Role of Vitagliptin and Vitamin D in the Treatment of Non Alcoholic Fatty Liver Disease (NAFLD)

NCT01083992 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

60

Enrollment

OTHER_GOV

Sponsor class

Conditions

Non-Alcoholic Fatty Liver Disease

Interventions

DRUG: Galvus (vitagliptin)
DRUG: Galvus + vitamin D

Sponsor

Ziv Hospital